Becton Dickinson and Co (BDX)
$221.9 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
7 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Becton Dickinson and Co, AI stock picks, stock alerts and much more.
BDX AI Stock Analysis
AI stock analysis for BDX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Becton Dickinson and Co (BDX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BDX Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Becton Dickinson and Co (BDX), currently trading at $221.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BDX
-
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
-
Symbol
BDX
-
Market
NYSE
-
Industry
Medical - Instruments & Supplies
-
Market Cap
64.1B
Similar Stocks
 |
Envista Holdings NVST |
$22.29 0.2% |
3 |
 |
Resmed RMD |
$249 0.1% |
5 |
 |
Baxter International BAX |
$33.71 1.7% |
6 |
 |
West Pharmaceutical Services WST |
$325.7 0.7% |
6 |
 |
Teleflex TFX |
$192.9 0.4% |
7 |
News
BDX Alternative Data
News Mentions
Sign up to access
Facebook Engagement
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Twitter Followers
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
BDX Financials
BDX Key Metrics
-
Total Revenue
$5B
-
Net Income
$487M
-
Earnings per Share
$1.68
-
Free cash flow
$1.1B
-
EBITDA
$1.3B
-
EBITDA Ratio
0.257114
-
Total Assets
$55.6B
BDX 2-year Revenue & Income
BDX 2-year Free Cash Flow
BDX Technicals
BDX SMA
BDX RSI
FAQ
What's the current price of Becton Dickinson and Co (BDX) Stock?
The price of an Becton Dickinson and Co (BDX) share is $221.9.
What's the market cap of Becton Dickinson and Co?
The current market cap of Becton Dickinson and Co is 64.1B.
Should I buy or sell BDX?
Becton Dickinson and Co shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Becton Dickinson and Co is better viewed as a hold or accumulate position while waiting for further developments.
Is Becton Dickinson and Co a good investment?
The current analysis of Becton Dickinson and Co's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Becton Dickinson and Co's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Becton Dickinson and Co (BDX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Becton Dickinson and Co stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Becton Dickinson and Co (BDX) that investors often compare it to?
Becton Dickinson and Co (BDX) is often compared to similar stocks such as Envista Holdings, Resmed, Baxter International, West Pharmaceutical Services and Teleflex.
What is the forecast for Becton Dickinson and Co's stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Becton Dickinson and Co's stock price to be around $224.8 in 2025. Starting from the current price of $221.9, this represents a 1.3% change in price, indicating a neutral outlook for the stock.
How to buy Becton Dickinson and Co (BDX) Stock?
Becton Dickinson and Co stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Becton Dickinson and Co shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.